| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00018187 |
Purpose
The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.
| Condition | Intervention | Phase |
|
Smoking |
Drug: Bupropion Drug: Mecamylamine Drug: Nicotine Patch |
Phase I |
| MedlinePlus related topics: | Smoking Smoking Cessation |
| ChemIDplus related topics: | Bupropion hydrochloride Bupropion Nicotine polacrilex Nicotine tartrate Mecamylamine Mecamylamine hydrochloride |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Combinations of Pharmacologic Smoking Cessation Treatments |
Eligibility
| Ages Eligible for Study: | 20 Years to 40 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Subjects must be a smoker between 20 and 40 years old, have smoked at least 20 cigarettes per day for at least 2 years, wish to stop smoking and be in good general health
Contacts and Locations More Information
| Study ID Numbers: | ADRD-011-98S |
| First Received: | July 3, 2001 |
| Last Updated: | May 7, 2007 |
| ClinicalTrials.gov Identifier: | NCT00018187 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
|
